Files
Abstract
Genomic screening is an increasingly important part of cancer care. Screening often detects somatic variants in the tumor sample of varied clinical significance: some are well understood, some are connected to only loose evidence, and some are unknown altogether. The purpose of this project was to construct a tool that could present state-of-the-art pathway information to genomics experts evaluating the clinical significance of variants.